Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1,805 MXN
Change Today 0.00 / 0.00%
Volume 0.0
As of 4:09 PM 04/20/15 All times are local (Market data is delayed by at least 15 minutes).

monsanto co (MON*) Snapshot

Open
$1,790
Previous Close
$1,805
Day High
$1,805
Day Low
$1,790
52 Week High
03/17/15 - $1,810
52 Week Low
10/13/14 - $1,433
Market Cap
859.4B
Average Volume 10 Days
112.0
EPS TTM
--
Shares Outstanding
476.1M
EX-Date
03/31/15
P/E TM
--
Dividend
$1.97
Dividend Yield
1.49%
Current Stock Chart for MONSANTO CO (MON*)

monsanto co (MON*) Details

Monsanto Company, together with its subsidiaries, provides agricultural products for farmers worldwide. It operates in two segments, Seeds and Genomics, and Agricultural Productivity. The Seeds and Genomics segment produces row crop seeds, including corn, soybean, cotton, and canola seeds principally under the DEKALB, Channel, Asgrow, and Deltapine brands; and vegetable seeds consisting of tomato, pepper, melon, cucumber, pumpkin, squash, beans, broccoli, onions, lettuce, and other seeds under the Seminis and De Ruiter brands. This segment also develops biotechnology traits that assist farmers in controlling insects and weeds in corn, cotton, and soybean crops under the SmartStax, YieldGard, YieldGard VT Triple, VT Triple PRO, and VT Double PRO, as well as Intacta RR2 PRO, Bollgard and Bollgard II, Roundup Ready and Roundup Ready 2 Yield, and Genuity brands; and licenses a range of germplasm and trait technologies to seed companies. The Agricultural Productivity segment manufactures and sells herbicides for agricultural, industrial, ornamental, turf, and residential lawn and garden applications for weed control, as well as for control of preemergent annual grass and small seeded broadleaf weeds in corn and other crops under the Roundup and Harness brands. The company sells its products through distributors, independent retailers and dealers, agricultural cooperatives, plant raisers, and agents, as well as directly to farmers. It has operations primarily in the United States, Europe, Africa, Brazil, Argentina, the Asia-Pacific, Canada, and Mexico. Monsanto Company has a collaborative agreement with Novozymes A/S to discover, develop, and produce microbial solutions. The company was formerly known as Monsanto Ag Company and changed its name to Monsanto Company in March 2000. Monsanto Company was founded in 2000 and is headquartered in St. Louis, Missouri.

22,400 Employees
Last Reported Date: 10/29/14
Founded in 2000

monsanto co (MON*) Top Compensated Officers

Chairman, Chief Executive Officer and Chairma...
Total Annual Compensation: $1.5M
President and Chief Operating Officer
Total Annual Compensation: $761.4K
Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $593.1K
Chief Technology Officer and Executive Vice P...
Total Annual Compensation: $646.4K
Executive Vice President, General Counsel and...
Total Annual Compensation: $593.1K
Compensation as of Fiscal Year 2014.

monsanto co (MON*) Key Developments

Monsanto Company Announces $800 Million Debt Offering

Monsanto Company announced the pricing of $800 million aggregate principal amount of fixed rate senior notes consisting of $300 million in senior notes that mature in 2025 and bear interest at a rate of 2.850%, $500 million in senior notes that mature in 2045 and bear interest at a rate of 3.950%. The company indicated that it expects to use the proceeds from the offering for general corporate purposes, which may include capital expenditures and share repurchases.

Monsanto Company Enters into $3 Billion Five-Year Revolving Credit Agreement

On March 27, 2015, Monsanto Company entered into a $3 billion, five-year revolving credit agreement (the Five-Year Credit Agreement) with certain lender parties thereto, JPMorgan Chase Bank, N.A., as administrative agent, Citibank, N.A., Bank of America, N.A. and Morgan Stanley Senior Funding Inc., as co-syndication agents, Barclays Bank plc, Goldman Sachs Bank USA, The Bank of Tokyo-Mitsubishi UFJ Ltd. and Wells Fargo Bank, National Association, as co-documentation agents, and J.P. Morgan Securities LLC, Citigroup Global Markets Inc., Merrill Lynch, Pierce, Fenner & Smith Incorporated and Morgan Stanley Senior Funding Inc., as co-lead arrangers and joint bookrunners. This agreement replaces the company's $2.5 billion four-year revolving credit agreement, dated as of April 1, 2011, as amended (the Prior Agreement). Under the terms of the Five-Year Credit Agreement, the company may obtain and utilize from time to time up to $3 billion, the amount of the aggregate commitments of the lenders, in revolving credit loans and competitive bid advances for general corporate purposes. The company may request increases in the lending commitments under the Five-Year Credit Agreement, but the aggregate lending commitments as increased may not exceed $3.75 billion. Borrowings under the Five-Year Credit Agreement may be made in US Dollars, Euros, Pounds Sterling and Yen. Borrowings (other than competitive bid advances) bear interest at a Eurocurrency Rate or the Base Rate, as defined in the Five-Year Credit Agreement. Up to $300 million of the total credit facility under the Five-Year Credit Agreement is available for the issuance of letters of credit in US Dollars. Additionally, up to $200 million of the total credit facility is available to the company for swing line loans in US Dollars, available on a same-day basis. The Five-Year Credit Agreement expires on March 27, 2020. Under circumstances specified in the Five-Year Credit Agreement, the company may request up to two one-year extensions of such termination date. The company has the right, subject to certain conditions set in the Five-Year Credit Agreement, to designate foreign subsidiaries of the company as borrowers under the Five-Year Credit Agreement. The company guarantees the obligations of any foreign subsidiary borrowers under the agreement.

Monsanto Company Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended February 28, 2015; Affirms Earnings Guidance for the Fiscal Year 2015

Monsanto Company announced unaudited consolidated earnings results for the second quarter and six months ended February 28, 2015. For the quarter, the company's net sales were $5,197 million compared with $5,832 million a year ago. Income from operations was $2,020 million compared with $2,418 million a year ago. Income from continuing operations before income taxes was $1,962 million compared with $2,340 million a year ago. Income from continuing operations including portion attributable to non controlling interest was $1,412 million or $2.90 per diluted share compared with $1,668 million or $3.15 per diluted share a year ago. Net income attributable to the company was $1,425 million or $2.92 per diluted share compared with $1,670 million or $3.15 per diluted share a year ago. EBIT was $2,043 million compared with $2,363 million a year ago. For the six months, the company's net sales were $8,067 million compared with $8,975 million a year ago. Income from operations was $2,439 million compared with $2,983 million a year ago. Income from continuing operations before income taxes was $2,289 million compared with $2,856 million a year ago. Income from continuing operations including portion attributable to non controlling interest was $1,639 million or $3.36 per diluted share compared with $2,032 million or $3.81 per diluted share a year ago. Net income attributable to the company was $1,668 million or $3.41 per diluted share compared with $2,038 million or $3.83 per diluted share a year ago. EBIT was $2,470 million compared with $2,917 million a year ago. Net cash provided by operating activities was $1,518 million compared with $1,846 million a year ago. Capital expenditures were $511 million compared with $471 million a year ago. The company affirmed earnings guidance for the fiscal year 2015. For the fiscal year 2015, the company diluted earnings per share in the range of $5.80 to $6.05 and diluted earnings per share from ongoing business in the range of $5.75 to $6.00, net cash provided by operating activities in the range of $3,000 million to $3,300 million, free cash flow in the range of $2,000 million to $2,200 million. The EPS guidance is inclusive of what is now expected to be a $0.35 to $0.40 headwind for this fiscal year driven by the significant deterioration of several key currencies versus the U.S. dollar.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MON*:MM $1,805.00 MXN 0.00

MON* Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Akzo Nobel NV €70.23 EUR -1.89
Givaudan SA SFr.1,766 CHF -22.00
SABMiller PLC 3,537 GBp -18.00
Solvay SA €134.35 EUR -2.05
Dow Chemical Co/The $51.24 USD -0.23
View Industry Companies
 

Industry Analysis

MON*

Industry Average

Valuation MON* Industry Range
Price/Earnings 25.4x
Price/Sales 3.8x
Price/Book 7.5x
Price/Cash Flow 23.8x
TEV/Sales 3.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MONSANTO CO, please visit www.monsanto.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.